Showing results (161-170 of 180) with videos related to

Sort By:
Pageof 18
Journal of Gastrointestinal Oncology|January 16, 2025
Balancing anticancer therapy efficacy and safety in advanced hepatocellular carcinoma: a case reportMohamad Mourad, Layal Al Mahmasani, Noura Abbas, et al.
Scientific Reports|November 28, 2022
68Ga-PSMA PET/CT in early relapsed prostate cancer patients after radical therapyMohamad Haidar, Alain S Abi-Ghanem, Hicham Moukaddam, et al.
Urology Annals|July 1, 2021
Comparative analysis of histopathological subtypes of renal cell carcinoma in the Middle East compared to other world regionsMark Khauli, Nassib Abou Heidar, Jad A Degheili, et al.
Journal of Gastrointestinal Oncology|January 13, 2023
Congenital cardiac liver cirrhosis with combined hepatocellular-cholangiocarcinoma-a case reportImane El Dika, Jinru Shia, Carol L Chen, et al.
BMC Microbiology|June 29, 2026
The gut microbiome in the Lebanese population and its alterations in metastatic colorectal cancer: benchmarking and applicationSally Temraz, Farah J Nassar, Pierre Bertrand, et al.
Ecancermedicalscience|November 26, 2021
COVID-19 vaccination immune response in patients with solid organ and haematologic malignancies: call for active monitoringLaudy Chehade, Jad Zeitoun, Rachelle Bejjany, et al.
Radiation Oncology (London, England)|September 9, 2017
Nadir PSA is a strong predictor of treatment outcome in intermediate and high risk localized prostate cancer patients treated by definitive external beam radiotherapy and androgen deprivationFady B Geara, Muhammad Bulbul, Raja B Khauli, et al.
JCO Global Oncology|February 8, 2020
High-Cost Cancer Treatment Across Borders in Conflict Zones: Experience of Iraqi Patients in LebanonMac Skelton, Raafat Alameddine, Omran Saifi, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|February 28, 2017
Prevalence of EGFR and ALK Mutations in Lung Adenocarcinomas in the Levant Area - a Prospective AnalysisArafat Tfayli, Hind Rafei, Alain Mina, et al.
Urology Annals|November 11, 2021
High rates of advanced prostate cancer in the Middle East: Analysis from a tertiary care centerMarilyne Daher, Talar Telvizian, Christelle Dagher, et al.
Pageof 18